At New Blue Health, our editorial goal is to provide the most accurate, reliable, and up-to-date information on peptide therapy, longevity science, and metabolic health. In an industry often clouded by misinformation, we maintain a strict editorial standard to ensure our readers and patients can make informed decisions about their health with confidence.
Our content is designed for educational purposes and is intended to empower individuals with clinical context. It does not replace the individualized medical advice of a licensed healthcare professional. Every piece of content published on our platform undergoes a multi-layered creation and review process.
Our Content Creation Process
1. Research: Our writers and clinical researchers begin by aggregating data from high-authority medical sources, including FDA labels, peer-reviewed clinical trials (RCTs), and academic institutional studies.
2. Drafting: Content is drafted with an emphasis on clarity, clinical accuracy, and educational scope. We avoid sensationalist language and focus on the mechanistic actions and evidenced outcomes of therapies.
3. Medical Review: Every article, guide, and molecule description is reviewed by a member of our licensed clinical team to ensure it aligns with current medical standards and safety protocols. See our Medical Review Policy.
Sourcing and Transparency
We prioritize primary sources and high-level clinical evidence. Our content is updated on a regular cadence—typically every 6 to 12 months—or whenever significant new clinical data or regulatory changes emerge in the peptide and longevity space. We are committed to transparency regarding the limitations of current research, especially in emerging fields where human data may still be developing.
All sources are cited directly within our educational guides or referenced in our central repository of clinical evidence. See our Sources.